3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases

Human Pathology

Volumn 40, Issue 10, 2009, Pages 1474-1478

  Alameda, Francesc ^a,b   Espinet, Blanca ^a,b   Corzo, Cristina ^a,b   Muñoz, Raquel ^b,c   Bellosillo, Beatriz ^a,b   Lloveras, Belén ^a,b   Pijuan, Lara ^a,b   Gimeno, Javier ^a,b   Salido, Marta ^a,b   Solé, Francesc ^a,b   Carreras, Ramon ^b,c   Serrano, Sergi ^a,b  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

Author keywords

3q26; FISH; hTERC; LSIL; Uterine cervix; viral load

Indexed keywords

PROTEN HTERC; RNA; TELOMERASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHROMOSOME 3Q; COLPOSCOPY; CONTROLLED STUDY; CYTOLOGY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; FROZEN SECTION; GENE AMPLIFICATION; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULAR PROBE; POSTMENOPAUSE; PREMENOPAUSE; SQUAMOUS EPITHELIUM; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DISEASE PROGRESSION; FEMALE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RNA; SENSITIVITY AND SPECIFICITY; TELOMERASE; UTERINE CERVICAL NEOPLASMS;

EID: 70049091746     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.03.013     Document Type: Article

References (7)

1. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2 (2002) 342-350
2. Heselmeyer K., Schröck E., du Manoir S., et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 93 (1996) 479-484
3. Rao P.H., Arias-Pulido H., Lu X.Y., et al. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer 4 (2004) 1-9
4. Hopman A.H., Theelen W., Hommelberg P.P., et al. Genomic integration of oncogenic HPV and gain of the human telomerase gene TERC at 3q26 are strongly associated events in the progression of uterine cervical dysplasia to invasive cancer. J Pathol 210 (2006) 412-419
5. Caraway N.P., Khanna A., Dawlett M., et al. Gain of 3q26 region in cervicovaginal liquid based pap preparations is associated with squamous intraepithelial lesions and squamous intraepithelial carcinoma. Gynecol Oncol 110 (2008) 37-42
6. Heselmeyer-Haddad K., Sommerfeld K., White N.M., et al. Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer. Am J Pathol 166 (2005) 1229-1238
7. Heselmeyer-Haddad K., Janz V., Castle P.E., et al. Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test of the diagnosis of cervical dysplasia. Am J Pathol 163 (2003) 1405-1416